PSMA-BCH

• UNSPSC Description:

  PSMA-BCH (NOTA-PSMA) is a NOTA-conjugated precursor. NOTA is a bifunctional chelate which acts as the framework to construct PET imaging tools[1].

• Target Antigen:

  Radionuclide-Drug Conjugates (RDCs)

• Type:

  Reference compound

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/psma-bch.html

• Solubility:

  DMSO : 125 mg/mL (ultrasonic)

• Smiles:

  O=C([C@@H]1CC[C@H](CC1)CNC(CN2CCN(CCN(CC2)CC(O)=O)CC(O)=O)=O)N[C@H](C(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)CC3=CC4=C(C=CC=C4)C=C3

• Molecular Weight:

  941.03

• References & Citations:

  [1]Teli Liu, et al. Synthesis and preclinical evaluation of 68Ga-PSMA-BCH for prostate cancer imaging. Bioorg Med Chem Lett. 2019 Apr 1;29(7):933-937.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1703768-73-3